INTRODUCTION
============

Multiple RNA silencing pathways in plants downregulate gene expression at transcriptional and post-transcriptional levels by generating small (s)RNAs, 21--24 nt in length ([@B1; @B2; @B3; @B4]). These sRNAs act either by guiding the cleavage of cognate RNAs, blocking productive translation of these RNAs, or inducing methylation of cognate DNA targets. The major pathways in *Arabidopsis* differ in the nature of sRNA precursors and requirements for Dicer-like (DCL) and RNA-dependent RNA polymerase (RDR) proteins. Micro (mi)RNAs are generated by DCL1 from hairpin structures of primary-miRNA transcripts. In contrast, endogenous small interfering (si)RNAs are generated by different DCLs from double-stranded (ds)RNA precursors produced by RDRs. For example, heterochromatic and repeat-associated siRNAs are generated by DCL3 from RDR2-dependent precursors, whereas *trans*-acting siRNAs (tasiRNAs) by DCL4 from RDR6-dependent precursors. Both miRNAs and siRNAs bind Argonaute (AGO) proteins and guide the resulting RNA-induced silencing complexes (RISCs) to the complementary region of target nucleic acids.

The present study focuses on effects of viral infection on the function and regulation of the tasiRNA-generating (TAS) pathways. Genetic evidence and limited biochemical data suggest that tasiRNA biogenesis is initiated by miRNA-mediated cleavage of a primary TAS transcript to generate a substrate for RDR6 that lacks the cap and/or the poly(A) tail. The presumed long dsRNA product of RDR6 activity is then processed by DCL4 from the miRNA-cleaved terminus into 21-nt siRNA duplexes with 2 nt 3′-overhangs ([Figure 1](#F1){ref-type="fig"}). TasiRNAs are encoded by both strands of dsRNA precursors and at different in-phase positions, 2--12 21 nt processing cycles from the site of miRNA cleavage ([@B5; @B6; @B7; @B8; @B9; @B10]). Figure 1.Models for the biogenesis of tasiRNAs from two distinct types of *Arabidopsis* tasiRNA-generating (*TAS*) loci. (**A**) For each type of tasiRNA biogenesis the TAS gene structure is shown schematically with the promoter indicated with an arrow shape. Pol II transcription driven by this promoter generates capped and polyadenylated transcript. This transcript is targeted for cleavage by miRNA. In the case of *TAS1*, *TAS2* and *TAS4* tasiRNA families (top), the 3′-product of this cleavage event is converted into dsRNAs by RDR6 activity. In the case of the TAS3 tasiRNA family (bottom), the 5′-product is converted into dsRNA by RDR6. In both cases, the resulting dsRNA is processed by DCL4 into 21-nt tasiRNAs. Suppression of the latter step by the CaMV TAV protein is inferred from the present study.(**B**) The hypothetical dsRNAs derived from the *Arabidopsis* Col-0 tasiRNA-generation loci *TAS1a*, *TAS1b*, *TAS1c*, *TAS2*, *TAS3a, TAS3b, TAS3c* and *TAS4* are shown schematically. In each case, position of the miRNA cleavage site is indicated by arrows; for TAS3 loci, position of the second, non-cleavable miR390-binding site is also shown. The 21-nt tasiRNAs of both sense (+) and antisense (--) polarities produced by DCL4-mediated, in-phase processing of the dsRNA are shown by boxes. The tasiRNAs probed in this study are in bold-lined boxes with their names indicated. The *TAS1* loci-derived siR255 and siR255-like species are in dark boxes. *TAS1a*- and *TAS1b*-derived siRNAs D1(+) species differ only at 5′-terminal nucleotide (U and A, respectively).

Four *Arabidopsis TAS* families with up to three distinct loci have been identified ([@B6],[@B9],[@B11]). *TAS1* and *TAS2* tasiRNAs are initiated by miR173, *TAS3* ones by miR390 and *TAS4* ones by miR828 ([Figure 1](#F1){ref-type="fig"}). The *TAS3* family is special in that the two functional tasiRNAs are encoded upstream of the miR390 cleavage site and that a second miR390 target site further upstream is not cleaved ([@B12]). The two miRNA target sites are thought to delimit the region of *TAS3* primary transcripts converted into dsRNA. Although target mRNAs for all four TAS families have been identified ([@B9]), biological functions have only been elucidated for *TAS3*-tasiRNAs that target the auxin-response factor genes *ARF3* and *ARF4* to control the juvenile-to-adult transition in leaf development ([@B13],[@B14]).

Recent evidence indicates that the AGO7 protein specifically associates with miR390 to target the *TAS3a* transcript and thereby initiate tasiRNA biogenesis ([@B15]). However, only the *TAS3* pathway genetically requires *AGO7* ([@B13]) and the biogenesis of tasiRNAs of other *TAS* families appear to be initiated by AGO1-RISC that associates with most miRNAs ([@B16],[@B17]). DRB4, a dsRNA binding (DRB) protein, has been implicated in tasiRNA biogenesis as a DCL4-binding partner ([@B18]). However, DRB4-deficient mutants still accumulate substantial levels of 21 nt tasiRNAs from *TAS1, TAS2 and TAS3* loci ([@B13],[@B19; @B20; @B21]), suggesting that DCL4 does not absolutely require DRB4 for processing dsRNA precursors of tasiRNAs or that DRB4 acts downstream of the processing step.

Certain protein coding genes give rise to siRNAs that depend on RDR6 for their production. Interestingly, many of these genes are targets of tasiRNAs and, in some cases, of miRNAs ([@B9],[@B12]). A common feature of such secondary siRNA-generating loci is that they are targeted by more than one small RNA. It has been proposed that successive amplification of secondary siRNAs by an RDR6-/DCL4-dependent mechanism might function to achieve efficient silencing of paralogous genes in expanding gene families ([@B9]). The same mechanism involving RDR6 and DCL4 appears to generate secondary siRNAs from silenced transgenes ([@B22]), which contribute to amplification and cell-to-cell spread of silencing ([@B20],[@B23]).

By analogy, RDR6-dependent production of secondary siRNAs might contribute to anti-viral defense based on RNA silencing ([@B24]). Indeed, RDR6 was implicated in defense against an RNA cucumovirus ([@B25]) and in exclusion of an RNA potexvirus from the shoot apical meristem ([@B26]).

Cauliflower mosaic virus (CaMV) is a pararetrovirus with a dsDNA genome and a polycistronic pregenomic RNA with seven genes ([@B27]). The transactivator/viroplasmin (TAV) is produced from a subgenomic monocistronic CaMV RNA, and this protein activates polycistronic translation of the remaining six proteins ([@B28]). TAV is multifunctional and equipped with the nuclear targeting and export signals ([@B29]), as well as ssRNA- and dsRNA- and protein-binding domains. It forms large cytoplasmic inclusion bodies, within which virus particles accumulate ([@B30]). TAV also determines symptom severity and host range ([@B31]) and, as a transgene, causes virus-like symptoms and late flowering ([@B32],[@B33]). Recently it was shown to act as a suppressor of transgene silencing ([@B34]).

We and others have previously reported that four *Arabidopsis* DCL proteins generate CaMV-derived siRNAs, 21, 22 and 24 nt in length ([@B35],[@B36]). The relative contribution of DCL4, known to restrict RNA virus infection ([@B37]) was minor, however, and RDR6 was not required for CaMV siRNA biogenesis ([@B35]), suggesting that *RDR6-/DCL4*-dependent amplification of viral secondary siRNAs is suppressed.

Here we report that CaMV infection interferes with endogenous *RDR6*-dependent tasiRNA and secondary siRNA pathways and demonstrate that TAV is solely responsible for this interference. Furthermore our work uncovers novel mechanistic features of tasiRNA-generating pathways and suggests feedback regulation of tasiRNA levels through activation of the tasiRNA biogenesis machinery.

MATERIALS AND METHODS
=====================

*Arabidopsis* mutant and transgenic lines
-----------------------------------------

*Arabidopsis* DCL- and RDR-deficient mutant lines *dcl2-5, dcl3-1, dcl4-2, dcl23, dcl34, dcl234, rdr6-15* and *rdr2-1* (all in Col-0 background) used in this study were described previously (35 and references therein). The CaMV TAV transgenic *Arabidopsis* lines CM-2, CM-6 and D4-2 (in Col-0 background) were constructed by Yu *et al.* ([@B38]). The silenced GFP transgenic *Arabidopsis* line GF-FGxGFP was described by Moissiard *et al.* ([@B22])

Plant growth and virus infection
--------------------------------

*Arabidopsis* wild-type, silencing-deficient mutant and TAV transgenic plants were raised from seeds in soil and maintained in a Phytochamber (Sanyo) at 20°C with 12-h light and 12-h dark. Four to five weeks post-germination, seedlings were inoculated with CaMV using particle bombardment as we described previously ([@B35],[@B39]): 1 μm gold particles were coated with 1-μg plasmid DNA of the CaMV CM1841 infectious clone pCa122 ([@B40]) and delivered at 1100 psi. CaMV symptoms started to develop about 3 weeks post-inoculation. One month post-inoculation, unless otherwise stated, the virus-infected plants were harvested and used for RNA extraction.

RNA extraction and analysis
---------------------------

Total RNA was extracted from 1-g plant tissue, derived from the pools of plants grounded into fine powder in liquid nitrogen, using Trizol reagent (Invitrogen, AG, Basel, Basel land, Switzerland) according to the manufacturer\'s protocol. About 20 or 30 μg total RNA were resuspended in 10 μl loading buffer (0.10% bromophenol blue in 100% de-ionized formamide), heated at 95°C for 2 min and loaded on 15% (or 5%) polyacrylamide denaturing gel (a 19 : 1 ratio of acrylamide to bis-acrylamide, 8 M urea). The gel was run using the SE 600 electrophoresis apparatus (Hoefer Inc., Holliston, MA, USA) at 300 V for 4 h and then RNAs were transferred to a Hybond N+ membrane by electroblotting in 1× TBE buffer at 10 V overnight. The hybridization was performed at 35°C for 18 to 24 h in UltraHyb-oligo buffer (Ambion, Warrington, Cheshire, UK) using as a probe, short DNA oligos ([Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)) end-labeled with ^32^P by polynucleotide kinase (New England Biolabs/Bioconcept, Allschwil, Basel land, Switzerland) and purified through MicroSpin™ G-25 columns (GE Healthcare, Glattbrugg, Zurich, Switzerland) according to the manufacturers' recommendations. The blot was washed two times with 2 × SSC, 0.5% SDS for 30 min at 37°C. The signal was detected after exposure to a phosphor screen using a Molecular Imager (BioRad). For repeated hybridization, the membrane was stripped with 0.5 × SSC, 0.5% SDS for 30 min at 80°C and then with 0.1 × SSC, 0.5% SDS for 30 min at 80°C.

Microarray analysis
-------------------

All microarray analyses were done using two replicates. For each replicate, three to four CaMV-infected or mock-inoculated plants and, in the case of TAV transgenic lines, nine transgenic or wt (Col-0) seedlings grown in soil as described above were harvested 1 month post-inoculation and 15 days post-germination, respectively. Total RNA was prepared by the Trizol method as described above and further purified using an RNeasy Plant Mini Kit (Qiagen, AG, Hombrechtikon, Zurich, Switzerland) following the manufacturer\'s recommendations. The quality of the isolated RNA was determined with a NanoDrop ND 1000 (NanoDrop Technologies) and a Bioanalyzer 2100 (Agilent Technologies). Only those samples with a 260 nm/280 nm ratio between 1.8--2.1 and a 28S/18S ratio within 1.5--2 were further processed. Total RNA samples (2 µg) were reverse-transcribed into double-stranded cDNA, *in vitro* transcribed in presence of biotin-labeled nucleotides using an IVT Labeling Kit (Affymetrix), purified and quantified using BioRobot Gene Exp---cRNA Target Prep (Qiagen). The labeled cRNA quality was determined using Bioanalyzer 2100. For array hybridization, biotin-labeled cRNA samples (15 µg) were fragmented randomly to 35--200 bp at 94°C according to the Affymetrix protocol. Samples were hybridized to GeneChip® Arabidopsis ATH1 Genome arrays for 16 h at 45°C. Arrays were then washed using an Affymetrix Fluidics Station 450 FS450 0004 protocol. An Affymetrix GeneChip Scanner 3000 (Affymetrix Inc.) was used to measure the fluorescent intensity emitted by the labeled target. Raw data processing was performed using the Affymetrix AGCC software. The normalized data were analysed using GeneSpring GX\* 7.3 (Agilent Technologies).

RESULTS
=======

TAV is responsible for CaMV infection-mediated interference with siR255 biogenesis
----------------------------------------------------------------------------------

CaMV infection in *Arabidopsis thaliana* causes overaccumulation of several *RDR6*-dependent precursors of *TAS1*-derived tasiRNA siR255 ([@B35]) ([Figure 2](#F2){ref-type="fig"}). To test whether the CaMV TAV protein implicated in silencing suppression contributes to this effect, we analyzed two *Arabidopsis* transgenic lines that constitutively express TAV proteins from the CaMV strains CM1841 and D4 (lines CM-2 and D4-2, respectively) ([@B38]). Both lines accumulate comparable levels of TAV, but the CM1841 TAV plants develop extensive chlorotic symptoms, whereas the D4 plants are nearly symptom-less ([@B38]). Blot hybridization analysis of total plant RNA using the siR255-specific probe showed that both transgenic lines accumulate, in addition to the 21-nt siR255, several precursors ranging in size from ∼35 to ∼600 nt. The sizes and relative abundances of these RNAs were very similar in both transgenic lines as well as in control Col-0 (wt) plants infected with CaMV strain CM1841. Moreover, CaMV infection of the TAV transgenic lines did not alter these patterns of RNA accumulation ([Figure 2](#F2){ref-type="fig"}). Notably, these long precursors of siR255 are also present in non-infected wt plants, albeit at very low levels ([Figure 2](#F2){ref-type="fig"} and data not shown). The levels of siR255 normalized for the U6 loading control were reduced to 55% of the wild-type levels in CaMV-infected plants. Of the two TAV transgenic lines, significant reduction in siR255 levels was observed only in the D4 line (see [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). The stronger interference with siR255 biogenesis in the D4 line than in the CM1841 line was also apparent from a higher ratio of the siR255 precursors (a total of several RNAs ranging from ∼35 to ∼600 nt) to the 21 nt siR255 product, compared to the CM1841 line ([Figure 2](#F2){ref-type="fig"}, see the imbedded table). Nonetheless, the CM1841 line accumulated somewhat higher amounts of the siR255 precursors. Figure 2.Accumulation of tasiRNA precursors in CaMV-infected and TAV transgenic plants. Total RNA from pools of CaMV-infected (+) or mock-inoculated (--) wild-type plants (Col-0) and TAV transgenic lines CM1841 and D4 harvested 1 month post-inoculation were analyzed by RNA blot hybridization (using 15% PAGE). Membranes were successively hybridized with DNA oligo probes for the tasiRNAs *TAS1a/b/c* siR255, *TAS3a* 5′D7(+), the miRNAs miR173, miR390 and miR828, CaMV-derived siRNAs and the small nuclear RNA U6 (see [Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1) for probe details). Positions of ssRNA markers are indicated. U6 signal serves as a loading control. The U6-normalized, relative levels of miRNAs are shown under the respective scan. The U6-normalized, relative levels of the tasiRNAs and the tasiRNA precursors (a total of several RNAs ranging from ∼35 to 600 nt) as well as the precursor/tasiRNA ratios are shown in the table. For each miRNA and tasiRNA, its accumulation in the uninfected, nontransgenic *Arabidopsis* (lane 1) was set to 1.0 (underlined). For the tasiRNA precursors, their accumulation was related to the corresponding tasiRNA.

We made a time-course analysis of the TAV effect on the siR255-generating pathway using pools of the transgenic and the wt plants harvested 15, 30 and 45 days post-germination. Wt plants bolted and started to flower 30--45 days post-germination, whereas the transgenic lines displayed slower growth and flowered 1 (CM1841) or 2 (D4) months later, confirming earlier observations ([@B32]). In the CM1841 line, the siR255 precursors were equally abundant at all three time points. In contrast, the D4 line accumulated lower amounts of the precursors at the two earlier time points ([Figure 3](#F3){ref-type="fig"}). Despite the difference in accumulation of the precursors, at each time point the precursors/tasiRNA ratio was about two to three times higher in the D4 line than in the CM1841 line ([Figure 3](#F3){ref-type="fig"}), confirming that TAV expression in the D4 line has a stronger negative impact on tasiRNA processing. Interestingly, the levels of miR173 that initiates the siR255-generating pathway ([Figure 1](#F1){ref-type="fig"}) were increased pronouncedly in the CM1841 line ([Figure 3](#F3){ref-type="fig"}), thus correlating with higher accumulation of the siR255 precursors. Figure 3.Differential impact of TAV proteins from CaMV strains CM1841 and D4 on TAS1 versus TAS3 tasiRNAs and their precursors. Total RNA from pools of noninfected, wild-type (Col-0) plants and TAV transgenic lines CM1841 and D4 harvested at 15, 30 and 45 days post-germination were analyzed by RNA blot hybridization (15% PAGE). Membranes were successively hybridized with DNA oligo probes for the tasiRNAs *TAS1a/b/c* siR255, *TAS1a/b/c* siR255\*, *TAS3a* 5′D7(+), *TAS3a* 5′D7(--), the miRNAs miR173, miR390 and miR172, and U6 (see [Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1) for probe details). U6 signal serves as a loading control. The U6-normalized, relative levels of the tasiRNAs and the tasiRNA precursors (a total of several RNAs ranging from ∼35 to 600 nt) as well as the precursor/tasiRNA ratios are shown in the two tables. The U6-normalized, relative levels of miRNAs are shown under the respective scan. For each miRNA and tasiRNA, its accumulation in the nontransgenic *Arabidopsis* at day 15 (lane 1) was set to 1.0 (underlined). For the tasiRNA precursors, their accumulation was related to the corresponding tasiRNA.

Further analysis of infected and TAV transgenic plants using probes specific for both strands of a presumed tasiRNA duplex (siR255/siR255\*) detected longer RNAs identical in size and relative abundance but negligible levels of 21-nt siR255\* ([Figure 3](#F3){ref-type="fig"}). These results, and our earlier findings for CaMV-infected wt plants ([@B35]) ([Figure 4](#F4){ref-type="fig"}) suggest that most larger-sized RNAs are potentially double-stranded molecules. Taken together, we conclude that the CaMV TAV protein is solely responsible for the CaMV-mediated interference with siR255 biogenesis. Figure 4.Impact of CaMV infection on the biogenesis of tasiRNAs from different *TAS* loci. Total RNA from pools of CaMV-infected (+) and mock-inoculated wild type (Col-0) plants harvested 1 month post-inoculation were analyzed by RNA blot hybridization (15% PAGE). Membranes were successively hybridized with DNA oligo probes for the tasiRNAs *TAS1a/b/c* siR255, *TAS1a/b/c* siR255\*, *TAS1a/b* 3′D1(+), *TAS1a/b* 3′D1(--), TAS2 siR612, TAS2 siR1940, *TAS3a* 5′D7(+), the miRNA miR173, the 5S rDNA repeat-associated siRNA siR1003 and U6 (see [Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1) for probe details). U6 signal serves as a loading control. Positions of ssRNA markers are indicated. Asterisks indicate the dsRNAs hybridized to both the internal (*TAS1a/b/c* siR255- and siR255\*-specific) and the miR173-terminal \[*TAS1a/b* 3′D1(+)- and 3′D1(--)-specific\] probes.

Analysis of dsRNA precursors of *TAS1* tasiRNAs
-----------------------------------------------

siR255 is encoded by three *TAS1* family loci *TAS1a*, *TAS1b* and *TAS1c* at processing positions 3′D6(+), 3′D6(+) and 3′D3(+), respectively, located six, six and three 21-nt cycles downstream of the miR173 cleavage site ([@B6]). Four additional siR255-like species are encoded by *TAS1a*, *TAS1b* and *TAS1c* ([Figure 1](#F1){ref-type="fig"}B, filled boxes). To further characterize the long RNAs that hybridize to the siR255- and the siR255\*-specific probes in CaMV-infected plants ([@B35]), we re-probed the respective blot with P-32 labeled, 21- and 19-nt-long DNA oligonucleotides ([Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)) complementary to the predicted *TAS1a* 21-nt siRNAs 3′D1(+) and 3′D1(--) ([Figure 1](#F1){ref-type="fig"}B). These probes are expected to hybridize to the termini of presumed dsRNAs from *TAS1a* and *TAS1b* with only 1-nt mismatch at the end but not to those from *TAS1c* and *TAS2* with \>4 mismatches. Such dsRNAs could be either the hypothetical full-length products of RDR6 activity or partially processed products from an end opposite to the miR173 cleavage site. We detected 21-nt *TAS1a* 3′D1(+) species in both mock control and CaMV-infected plants, but no 3′D1(--) species ([Figure 4](#F4){ref-type="fig"}). Both *TAS1a* 3′D1 (+) and 3′D1(--) specific probes also strongly hybridized to four of the 12 longer RNAs detectable with siR255- and siR255\*-specific probes in CaMV-infected plant samples (indicated with asterisks in [Figure 4](#F4){ref-type="fig"}).

We also analyzed the siR255 precursors in DCL-deficient single, double and triple mutants *dcl2, dcl3, dcl4*, *dcl23*, *dcl34* and *dcl234* as well as RDR-deficient mutants *rdr2* and *rdr6*, described earlier ([@B35]). To better resolve longer precursors of tasiRNAs and identify single-stranded (ss) *TAS1* transcripts of 800--1000 nt, total RNA was separated using 5% PAGE ([Figure 5](#F5){ref-type="fig"}B) and low-molecular-weight RNAs were separated using 18% PAGE ([Figure 5](#F5){ref-type="fig"}A). The size range of the single-stranded, siR255-containing RNAs we detected ([Figure 5](#F5){ref-type="fig"}B) corresponded to *TAS1a*, *1b* and *1c* transcripts of 929, 838 and 989 nt in length, respectively. Strikingly, accumulation of most *TAS1*-derived RNAs was perturbed in the *dcl4* mutant backgrounds relative to the wt and the other *dcl* mutants ([Figure 5](#F5){ref-type="fig"}A and B). Thus, these RNAs may represent intermediates of DCL4-mediated processing of the longest (full-length) dsRNA precursors of 500--600 bp, which accumulated equally in the wt and all the *dcl* mutant plants infected with CaMV ([Figure 5](#F5){ref-type="fig"}B). In the absence of DCL4, other DCLs appear to compensate for its deficiency: abundant 22-nt sRNA and several longer intermediates accumulating in *dcl4* and *dcl34* are DCL2-dependent ([Figure 5](#F5){ref-type="fig"}A and B). The 24- and 25-nt sRNAs and two RNAs migrating at the *ca*. 80-nt position are DCL3-dependent ([Figure 5](#F5){ref-type="fig"}A). The RNA pattern in *dcl234* indicates that full-length precursors of siR255 are partially processed by DCL1 resulting in a distinct pattern of RNA intermediates but no detectable siRNAs ([Figure 5](#F5){ref-type="fig"}). Finally, none of the precursors or mature *TAS1* tasiRNAs was detected in *rdr6* but all were detected in *rdr2* ([Figure 5](#F5){ref-type="fig"}A), showing that RDR6 is required for biogenesis of these tasiRNA precursors. Similar results were obtained for precursors and tasiRNAs encoded by *TAS2 and TAS3* loci (data not shown). Figure 5.Dissection of the siR255-generating pathway in CaMV-infected *DCL*- and *RDR*-deficient mutants. RNA samples from CaMV-infected wild type (Col-0), the single (*dcl2-5*, *dcl3-1* and *dcl4-2*), double (*dcl2 dcl3*, *dcl3 dcl4;* 35) or triple (*dcl2 dcl3 dcl4;* 35) DCL-deficient and the RDR2- (*rdr6-15*) and the RDR6-deficient (*rdr2-1*) mutants harvested 1 month post-inoculation were analyzed by RNA blot hybridization using 18% PAGE for low-molecular-weight RNA (**A**) and 5% PAGE for total RNA (**B**). Membranes were successively hybridized with DNA oligo probes for *TAS1a/b/c* siR255, *TAS1a/b/c* siR255\*, miR173, CaMV siRNAs and U6 (see [Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1) for probe details). U6 signal serves as a loading control. Positions of ssRNA markers are indicated. The dsRNAs hybridized to the miR173-terminal \[*TAS1a/b* 3′D1(+)- and 3′D1(−)-specific\] probes in [Figure 4](#F4){ref-type="fig"} are indicated by asterisks.

CaMV infection and TAV expression interfere with the pathways generating the four known tasiRNA families
--------------------------------------------------------------------------------------------------------

We also investigated if expression of the *TAS2-TAS4* families was affected by CaMV infection. The single *TAS2* locus encodes siR614 and siR1940 species as the fifth cycle duplex \[3′D5(+) and 3′D5(--)\] downstream of the miR173 site ([@B6]) ([Figure 1](#F1){ref-type="fig"}B). In uninfected plants, the probes specific for these tasiRNAs identified the expected 21-nt molecules. CaMV infection induced the accumulation of four additional longer RNAs, whose sizes were similar in both polarities ([Figure 4](#F4){ref-type="fig"}). A similar pattern of *TAS2* long dsRNAs was found in the two TAV transgenic lines, with higher levels accumulating in the CM1841 line and a higher precursor/tasiRNA ratio in the D4 line ([Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). These findings indicate that CaMV infection and expression of TAV proteins interfere in a similar manner with miR173-initiated, *TAS1* and *TAS2* pathways.

The miR390-initiated tasiRNAs are derived from three loci of the *TAS3* family ([Figure 1](#F1){ref-type="fig"}), with *TAS3a* giving rise to most of the sRNA reads ([@B9]). The *TAS3a*-specific tasiRNA 5′D7(+) but not its passenger strand 5′D7(--) was detected. Both sense and antisense probes detected long precursors of *TAS3a* tasiRNAs in CaMV-infected, but not mock-inoculated, wt plants and in both TAV transgenic lines ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Note that these precursors were much less abundant in CaMV-infected plants than in the TAV transgenic lines ([Figure 2](#F2){ref-type="fig"}). In contrast to *TAS1* and *TAS2*, the *TAS3a* tasiRNA precursors were more abundant in the D4 line than in the CM1841 line and were inversely correlated in abundance with their mature tasiRNAs ([Figure 3](#F3){ref-type="fig"}). Nonetheless, the precursors/tasiRNA ratio was comparable for both *TAS3a* and *TAS1/TAS2* in the D4 line, whereas it was higher for *TAS1/TAS2* than *TAS3a* in the CM1841 line ([Figure 3](#F3){ref-type="fig"}). This suggests that TAV expression in the D4 line exerts strong and comparable effects on both the miR173- and the miR390-initiated tasiRNA biogenesis, whereas TAV expression in the CM1841 line has generally weaker effects on both but a more pronounced effect on the miR173-initiated tasiRNA biogenesis.

The miR828-initiated tasiRNAs derived from the single *TAS4* locus ([@B11]) are of very low abundance ([@B9]). We did not detect any small RNA in control Col-0 plants with the probes specific for the cloned 21 nt *TAS4* siR81(--) species or its passenger strand. In both CaMV-infected and TAV transgenic plants, however, ∼24--26 nt small RNA of one polarity was detected using the siR81(--)-specific probe ([Figures 4](#F4){ref-type="fig"} and S1). This probe, but not its reverse complement (data not shown), detected long RNAs that were equally abundant in control and CaMV-infected plants, but overaccumulated in TAV transgenic plants. At least one distinct long RNA appears to be CaMV TAV-specific (indicated with asterisk in [Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Thus, CaMV infection and TAV expression both interfere with the *TAS4* biogenesis.

CaMV infection and TAV expression upregulate both tasiRNA targets and components of tasiRNA biogenesis
------------------------------------------------------------------------------------------------------

Our finding that TAV expression dramatically increased the accumulation of tasiRNA precursors and the ratio of precursors to tasiRNA suggests that TAV impairs processing of RDR6-dependent dsRNA to tasiRNA by DCL4. However, the levels of tasiRNAs themselves are not drastically reduced in CaMV-infected or TAV D4 plants, and, in some samples of the CM1841 plants, are even slightly increased ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). This could be due to incomplete spatial and/or temporal overlap of viral infection (TAV protein production) and the tasiRNA biogenesis and activity pathways. Additionally, a feedback regulation may partially or fully restore normal levels of tasiRNAs. We therefore investigated if the action of tasiRNAs in knocking down their target gene transcripts is affected and whether the genes mediating tasiRNA biogenesis are regulated in CaMV-infected and TAV transgenic plants. Using the ATH1 whole-genome microarray, we profiled total RNA from CaMV-infected versus mock-inoculated wt (Col-0) and tasiRNA-deficient *dcl234* plants (harvested 1 month post-inoculation) as well as from non-infected transgenic versus wt (Col-0) plants harvested 15 days post-germination. Confirming the above time-course experiment ([Figure 3](#F3){ref-type="fig"}), the siR255 precursors were more abundant in the CM1841 than in the D4 line samples ([Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1); note that, of the two independent, CM1841 TAV-expressing lines shown, CM-2 was profiled). Notably, the TAV transgene transcript levels were higher in the D4 line than in the two CM1841 lines CM-2 and CM-6 ([Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)), which is consistent with slightly higher accumulation of TAV protein and its breakdown products in this D4 line (D4-2) compared to the CM1841 lines (38; and data not shown). The higher expression of TAV protein in the D4 line might account for the stronger negative impact on tasiRNA biogenesis in this line as inferred above from the dsRNA precursors/tasiRNA ratios. However we cannot exclude that 5% difference at the amino acid level between the two TAV proteins is responsible for the observed effects.

The microarray analysis showed that the key genes involved in tasiRNA biogenesis including *DCL4*, *DRB4* and *AGO7* were upregulated by both CaMV infection and TAV expression ([Figure 6](#F6){ref-type="fig"}A, [Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)), thus supporting the feedback regulation hypothesis. Notably, the D4 line exhibited a more pronounced upregulation of these genes than the CM1841 line. Additionally, *DCL1 and RDR6* were found to be modestly upregulated in the D4 line ([Figure 6](#F6){ref-type="fig"}A, [Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). The transcript levels of *DRB4* and *AGO7* were elevated to similar levels in both CaMV-infected wild-type and *dcl234* plants ([Figure 6](#F6){ref-type="fig"}A, [Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Interestingly, residual levels of a *DCL4* transcript were detected in *dcl234* carrying a T-DNA insertion in the 23rd exon of the *DCL4* gene and those were also slightly elevated upon CaMV infection. Furthermore, *DCL1* was also modestly upregulated in CaMV-infected *dcl234* ([Figure 6](#F6){ref-type="fig"}A, [Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Other genes presently implicated in the miRNA- and tasiRNA-generating pathways, namely *AGO1, HYL1/DRB1*, *HEN1*, *SE*, *SGS3* and *SDE5* were not affected by the CaMV challenges. Of the silencing-related genes not implicated in the tasiRNA pathway so far, notable CaMV-mediated upregulation was found for *AGO2, TOUSLED, NRPD1a, DDM1, DME, HDA18, RPA2* and *FAS2*, whereas *DRB3* was downregulated (data not shown). Figure 6.Response of the *Arabidopsis* transcriptome to CaMV infection and TAV transgene expression reveals the interference with the tasiRNA and secondary siRNA pathways. The microarray analysis data for CaMV-infected (+) and mock-inoculated (--) *Arabidopsis* wt (Col-O) and the *dcl2 dcl3 dcl4* triple mutant (*dcl234*) plants as well as for the CaMV TAV transgenic lines CM1841 and D4 are presented as the bar charts with error bars showing standard deviation from mean value of the normalized expression levels (Tables S2--S4) of the genes upregulated in response both to CaMV infection (in Col-0 and *dcl234*) and TAV expression (in CM1841 and/or D4). The data are for two samples, each representing a pool of three (or, in the case of TAV transgenic lines, nine) plants. The statistically significant changes are indicated by asterisks. (**A**) shows the genes mediating tasiRNA biogenesis (DCL4, DRB4, AGO7, DCL1 and RDR6), (**B**) the genes targeted by tasiRNAs of the four *TAS* families (indicated in brackets) and (**C**) the miRNA targets (the miRNA indicated in brackets) and other genes silenced by secondary siRNAs.

Further analysis of the microarrays revealed that several predicted tasiRNA target genes were modestly upregulated by CaMV infection ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). These included (i) two 'expressed protein' genes targeted by siR255 and three other tasiRNAs encoded by the *TAS1 a/b/c* loci, (ii) six *PPR* genes targeted by single or multiple siRNAs derived from *TAS1a* or *TAS2* loci, (iii) *AFR4* targeted by two *TAS3a* siRNAs and (iv) *MYB113* targeted by the *TAS4* siR81(--). Thus, subsets of the targets for all the known *TAS* families were elevated. Most of these were also upregulated in noninfected *dcl234* plants, consistent with the tasiRNA deficiency. Interestingly, the target genes unaffected in the noninfected *dcl234* plants were upregulated when these plants were infected with CaMV ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Subsets of targets for tasiRNA in all four *TAS* families were also elevated in TAV transgenic lines ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). The target genes affected and the degree of upregulation depended on both the TAV line and the *TAS* family. The CM1841 TAV expression had the most pronounced effect on the *TAS4* targets with all three known targets of siR81(--) being strongly upregulated, while its effect on the *TAS1* and *TAS3* targets was less pronounced and on the *TAS2* targets rather negligible. In contrast, the D4 TAV expression had almost no effect on the *TAS4* targets, whereas most of the TAS2 targets were strongly upregulated ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Furthermore, one of the two *TAS1* targets and the *TAS3* target *ARF4* were more pronouncedly upregulated in the D4 line than in the CM1841 line, and the D4 line showed slightly elevated levels of the second *TAS3* target, *ARF3* ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)).

The gene *At2g39680* imbedded within *TAS2* (At2g39681) in opposite orientation ([@B7]) was upregulated upon CaMV infection and in both TAV transgenic lines ([Figure 6](#F6){ref-type="fig"}B, [Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Together with the earlier report on its upregulation in *rdr6* ([@B41]), our data suggest that At2g39680 is a target of *TAS2*-derived tasiRNAs, the biogenesis of which is impaired by CaMV TAV.

Many targets of tasiRNAs give rise to *RDR6*-dependent secondary siRNAs, likely to be involved in amplification of silencing ([@B9]). Thus, CaMV TAV-mediated interference with secondary siRNA production could account for upregulation of some of the tasiRNA targets ([Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)). Our further inspection of the transcriptome profiles revealed that both CaMV infection and TAV expression (in one or both lines) cause upregulation of several other *Arabidopsis* genes ([Figure 6](#F6){ref-type="fig"}C, [Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1)) that normally give rise to *RDR6*-dependent secondary siRNAs ([@B9]). Interestingly, many of these genes are targets of miRNAs, like the *TAS* genes themselves. Notably, TAV expression in the D4 line elevated transcript levels for most of these genes, whereas the CM1841 line showed elevated levels for only a few of them ([Figure 6](#F6){ref-type="fig"}C), which is similar to the above observations for the *TAS2* targets ([Figure 6](#F6){ref-type="fig"}B). The vast majority of other miRNA targets, which does not give rise to secondary siRNAs, was not upregulated in CaMV-infected or TAV transgenic plants (data not shown), suggesting that TAV does not interfere with miRNA action. The notable exception is *AGO1*, which represents an miRNA target gene generating secondary siRNAs that was not upregulated by TAV (data not shown). However, expression of this gene is auto-regulated at both post-transcriptional and transcriptional levels by a complex fine-tuning mechanism ([@B42]), which could fully compensate for the inhibitory effect of TAV.

CaMV interferes with production of *RDR6*-dependent secondary siRNAs from a silenced transgene
----------------------------------------------------------------------------------------------

Our transcriptome analysis suggests that TAV interferes with RDR6-dependent secondary siRNA pathways. To test this hypothesis we used the *Arabidopsis* GFP × GF-FG transgenic line ([@B22]), which carries a green fluorescent protein (GFP) transgene driven by the CaMV 35S promoter and a second transgene expressing an inverted repeat cognate to the GF portion of the GFP coding region (GF-FG). In this system, the 21-nt primary siRNAs produced by *DCL4*-mediated processing of the GF-FG dsRNA are thought to target the GFP transcript for cleavage and degradation. The latter process triggers *RDR6*-dependent production of secondary siRNAs from the P region of the GFP transgene ([Figure 7](#F7){ref-type="fig"}A). The *rdr6* mutation introduced into the GFP × GF-FG line has been shown to eliminate the secondary siRNAs without affecting accumulation of primary siRNAs or GFP silencing ([@B22]). CaMV infection of the GFP × GF-FG line did not result in re-appearance of GFP fluorescence under UV light (data not shown), indicating that GFP silencing was not suppressed. Consistent with the silenced GFP phenotype, RNA blot hybridization of total plant RNA with probes specific to the GF region showed that accumulation of primary siRNAs of both polarities was not reduced but rather slightly increased ([Figure 7](#F7){ref-type="fig"}B). In contrast, accumulation of secondary siRNAs from the P region was substantially reduced during viral infection ([Figure 7](#F7){ref-type="fig"}B). These results suggest that CaMV infection selectively interferes with the biogenesis of *RDR6*-dependent secondary siRNAs without any substantial effect on the production of primary siRNAs and their action in silencing GFP expression. Figure 7.CaMV infection interferes with the biogenesis of secondary siRNAs derived from the GFP transgene silenced by GF-FG dsRNA. (**A**) Model for the biogenesis of the primary (GF) and the secondary (P) siRNAs derived from the GF-FG and the GFP transgenes, respectively, in the transgenic GF-FG × GFP line. The structures of the two transgenes present in this line as shown schematically, with the CaMV 35S promoter indicated by an arrow shape. In the GF-FG transgene the inverted repeat of the GF region of the GFP coding sequence is equipped with an intron. The Pol II transcription generates a GF-FG transcript that folds back into perfect dsRNA. The latter is processed by DCL4 (and DCL3) into primary siRNAs (GF). These siRNAs target *in trans* a GFP mRNA transcribed from the GFP transgene for cleavage at multiple positions within the GF region. The 3′-product of these cleavage events retaining an intact P region is converted by RDR6 into dsRNA. The resulting dsRNA is processed by DCL4 (and DCL3) into secondary siRNAs (P). The later step is selectively impaired by CaMV infection as inferred from the following experiment.(**B**) Total RNA from CaMV-infected (+) and mock-inoculated (--) transgenic GF-FG X GFP line plants harvested 1 month post-inoculation were analyzed by RNA blot hybridization (15% PAGE). Membranes were successively hybridized with DNA oligo probes specific for sense and antisense siRNAs derived from the GF and P regions of the GFP coding sequence and U6 (see [Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkn590/DC1) for probe details). U6 signal serves as a loading control. The U6-normalized, relative levels of siRNAs are shown under the respective scans. In each case, the siRNA accumulation in the noninfected *Arabidopsis* was set to 1.0 (underlined).

DISCUSSION
==========

TAV interferes with RDR6-/DCL4-dependent silencing systems
----------------------------------------------------------

We established that the CaMV TAV protein, whether expressed from the viral genome or from a transgene, interferes with *Arabidopsis* tasiRNA-generating pathways. This interference is associated with (i) overaccumulation of unprocessed, RDR6-dependent precursors of tasiRNAs; (ii) increased levels of some *Arabidopsis* mRNAs normally silenced by tasiRNAs of four known *TAS* families; and (iii) upregulation of genes encoding DCL4, DRB4 and AGO7, which are involved in tasiRNA biogenesis. We also found that CaMV TAV interferes with RDR6-dependent secondary siRNA pathways. The latter finding is consistent with the ability of TAV to suppress amplicon transgene-induced silencing ([@B34]) that depends on *RDR6* ([@B43]). Furthermore, CaMV siRNAs accumulating in infected plants are largely *RDR6*- and *DCL4*-independent (35; [Figure 5](#F5){ref-type="fig"}A). Taken together, these findings suggest that TAV suppresses silencing by preventing *RDR6*-/*DCL4*-dependent amplification of secondary siRNAs.

TAV might act at the step of DCL4-mediated processing of RDR6-dependent dsRNA
-----------------------------------------------------------------------------

The available evidence suggests that TAV impairs processing of RDR6-produced dsRNA to small RNAs. In the case of tasiRNAs, this is likely to occur in an RDR6/DCL4 processing center believed to recruit *TAS* transcripts targeted for cleavage by miRNAs ([@B15]). This processing center might also generate secondary siRNAs from some genes targeted by miRNAs or primary siRNAs ([@B9]). Exactly how TAV inhibits processing is not known. One possibility, which we favor, is that TAV interacts with a protein or proteins in the processing center downstream of RDR6 ([Figure 1](#F1){ref-type="fig"}A). Potential targets include dsRNA-binding proteins, such as DRB4, which is known to interact with DCL4 ([@B18]), or DCL4 itself. Another possibility, which is not mutually exclusive, is that TAV binds dsRNA precursors and thereby inhibits their processing to siRNAs by DCL4. While this hypothesis is consistent with the presence of a conserved dsRNA-binding motif in TAV ([@B44],[@B45]), we have not been able to detect binding of TAV to either long dsRNA and short RNA duplexes (Shivaprasad,P.V. and Burgyan,J., unpublished data) using a sensitive assay ([@B46]). Moreover, several lines of evidence suggest that binding of TAV to dsRNAs *per se* is not sufficient to block downstream processing. Thus, we found that, in the presence of TAV, DCLs can still efficiently process non-RDR-derived dsRNAs such as a fold-back structure of the GF-FG transcript ([Figure 7](#F7){ref-type="fig"}). Similarly, *RDR6*-/*RDR2*-independent primary CaMV siRNAs presumably processed from dsRNAs derived from sense and antisense viral transcripts ([@B35]) were not affected by TAV overexpression in transgenic plants ([Figure 2](#F2){ref-type="fig"}). In future studies, it will be interesting to analyze how TAV-mediated suppression selectively impairs processing of RDR6 products and identify which DCL4 co-factor could be responsible for selective action of DCL4 on such dsRNA substrate.

Novel features of tasiRNA pathways
----------------------------------

Our functional characterization of TAV uncovered novel mechanistic and regulatory features of tasiRNA-generating pathways. RDR6-dependent, potentially double-stranded precursors of tasiRNAs, which overaccumulated in the presence of TAV, had been previously inferred from small RNA cloning and genetic evidence ([@B6]) but escaped detection so far. Using *dcl* mutants and RNA blot hybridization analysis, we verified that these precursors are preferentially processed by DCL4 and identified intermediates (and/or byproducts) of this processing. Notably, the estimated sizes of the longest (full-length) *TAS1*-derived RDR6-dependent sense and antisense RNAs fall into a range of 450--600 nt ([Figure 5](#F5){ref-type="fig"}B), suggesting that complete products of miR173-guided cleavage of *TAS1* transcripts are converted by RDR6 into dsRNA. It was proposed that *TAS1*- and *TAS2*-derived dsRNAs are preferentially processed from the miRNA cleavage site terminus ([@B6]). Unexpectedly, we discovered that some abundant, *DCL4*-dependent, shorter-than-full-length *TAS1* sense and antisense RNAs retain the miR173-cleavage site terminus ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). This might be due to processing of *TAS1* dsRNA precursors from the opposite side. Alternatively, at a first round of tasiRNA biogenesis, certain antisense tasiRNAs produced from the full-length dsRNAs might target the miR173-cleaved ss*TAS* transcript and thus create secondary, shorter substrates for RDR6. Such a two hit trigger mechanism has been proposed for biogenesis of *TAS3*-derived tasiRNAs as well as for secondary siRNAs derived from some *Arabidopsis* protein-coding genes ([@B9],[@B12]). Our work in progress aims to precisely map the termini of the full-length precursors of tasiRNAs and their derivatives described here, which should lead to new insight in the biogenesis of tasiRNAs and other RDR6-dependent siRNAs.

Our transcriptome analysis suggests that the tasiRNA pathway is subject to negative auto-regulation. TAV impairs processing of tasiRNAs and secondary siRNAs, leading to increased accumulation of their target transcripts. But it also upregulates genes coding for proteins that mediate siRNA biogenesis, including *DCL4, DRB4* and *AGO7*. Together with the rather modest effects of TAV expression on target genes, this implies that deficiencies in the tasiRNA pathway can lead to a compensatory activation of the key pathway components that partially or fully restores tasiRNAs and target mRNA levels. This hypothesis explains the difference observed for the two distinct TAV transgenic lines, one of which (D4) accumulating higher levels of target mRNAs and lower levels of tasiRNAs than the other (CM1841), at least for *TAS1*, *TAS2* and *TAS3* pathways (see [Figures 3](#F3){ref-type="fig"}, [6](#F6){ref-type="fig"} and S2, respectively). This would imply more efficient, feedback-mediated restoration of the tasiRNA and mRNA target levels in the CM1841 line than in the D4 line. Nonetheless in both lines, as a net effect of the ongoing TAV-mediated inhibition of tasiRNA processing and the feedback upregulation of tasiRNA biogenesis, the unprocessed precursors of *TAS1*, *TAS2* and *TAS3* tasiRNAs overaccumulate. The miRNA pathway genes *DCL1* ([@B11],[@B47]) and *AGO1* ([@B42]) are known to be auto-regulated. Our study supports the view that negative feedback regulation is a general feature of small RNA silencing pathways in plants. The mechanism of feedback regulation of the tasiRNA pathway remains to be investigated. Like in the case of miRNA-mediated regulation of *DCL1* and *AGO1* ([@B11],[@B42], [@B47]), the mRNAs of *DCL4, DRB4 and AGO7* may be targeted by some tasiRNAs and/or secondary siRNAs, the biogenesis of which is mediated by the DCL4, DRB4 and AGO7 proteins. Therefore, TAV-mediated interference with the biogenesis of such siRNAs would elevate the levels of the respective mRNAs. To our knowledge, no RDR6-dependent siRNA cognate to *DCL4*, *DRB4* or *AGO7* sequences have been reported.

TAV might suppress RNA-silencing based antiviral defense
--------------------------------------------------------

Virus infection involves a complex interplay of host defense mechanisms and counter-defense mechanisms of the virus ([@B24],[@B48]). We believe that one function of TAV is to suppress host defense mechanisms concerned with restricting virus spread by systemic RNA silencing. RDR6-/DCL4-dependent mechanisms generating secondary siRNAs from silenced transgenes ([@B22]) and endogenous genes ([@B9]), which are inhibited by TAV, appear to contribute to the amplification and spread of transgene silencing ([@B20],[@B23]). RDR6 is required for exclusion of potato virus X from shoot apical meristem ([@B26]) and defense against cucumber mosaic virus ([@B25]). We propose that by interfering with the amplification of CaMV secondary siRNAs, TAV reduces the effectiveness of systemic silencing. This is consistent with the finding that secondary viral siRNAs do not appear to accumulate in CaMV-infected tissues: most CaMV siRNAs are *RDR6*-independent (35; [Figure 5](#F5){ref-type="fig"}A), while DCL4, which restricts RNA-virus infection through production of 21-nt viral siRNA ([@B37]), makes only a minor contribution to production of CaMV siRNAs (35; [Figure 5](#F5){ref-type="fig"}A).

Many viruses overcome host defenses by expressing viral proteins that suppress RNA silencing ([@B48]). Overexpression of these suppressors in transgenic plants often results in developmental abnormalities that result from the interference of these proteins with the miRNA pathway ([@B49]). Thus, some abnormalities associated with virus infection may be 'collateral' effects of the viruses counter-defense to RNA silencing. Finally, the functional redundancy of components of the miRNA pathway and their negative auto-regulation by miRNAs might be additional layers of host defense. We assume that a similar interplay between host and virus defenses affects tasiRNA and other secondary siRNA pathways targeted by TAV. While our data show that TAV does not generally affect miRNA pathways, overexpression of TAV in transgenic plants leads to various abnormalities including delayed flowering (32,33,38; and this study) that appear to be correlated with inhibition of tasiRNA processing. Interestingly, recent studies using the GF-FG × GFP transgenic line established that suppressor proteins of two RNA viruses, the potyvirus HC-Pro and the carmovirus P38, interfere with the accumulation of secondary, but not primary, GFP siRNAs and endogenous *TAS1*-derived tasiRNAs ([@B22]). Feedback regulation in the *TAS* pathway may well explain conflicting findings that HC-Pro transgene expression does ([@B22]) or does not ([@B50]) affect accumulation of *TAS1* tasiRNAs.

Endnote
-------

While the manuscript of this paper was under review, Haas *et al.* ([@B51]) reported that transgene expression of TAV protein from the CaMV Cabb B-JI strain suppresses silencing through physical interaction with DRB4 protein, which leads to reduction of siR255 levels. They also reported that siR255 precursors accumulate in a *drb4* mutant line. Thus, their work confirms our findings for the CaMV D4 TAV line and further suggests that TAV binding to DRB4 might interfere with DCL4-DRB4 co-operation in processing tasiRNAs, which would in turn trigger the feedback upregulation of tasiRNA biogenesis components including *DCL4, AGO7* and *DRB4* itself as reported here.
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